AAAAAA

   
Results: 1-3 |
Results: 3
Comparison of poly-N-acetyl glucosamine (P-GlcNAc) with absorbable collagen (Actifoam), and fibrin sealant (Bolheal) for achieving hemostasis in a swine model of splenic hemorrhage
Authors: Chan, MW Schwaitzberg, SD Demcheva, M Vournakis, J Finkielsztein, S Connolly, RJ
Citation: Mw. Chan et al., Comparison of poly-N-acetyl glucosamine (P-GlcNAc) with absorbable collagen (Actifoam), and fibrin sealant (Bolheal) for achieving hemostasis in a swine model of splenic hemorrhage, J TRAUMA, 48(3), 2000, pp. 454-457
Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination
Authors: Maitre, N Brown, JM Demcheva, M Kelley, JR Lockett, MA Vournakis, J Cole, DJ
Citation: N. Maitre et al., Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination, CLIN CANC R, 5(5), 1999, pp. 1173-1182
A pilot study evaluating the efficacy of a fully acetylated poly-N-acetyl glucosamine membrane formulation as a topical hemostatic agent
Authors: Cole, DJ Connolly, RJ Chan, MW Schwaitzberg, SD Byrne, TK Adams, DB Baron, PL O'Brien, PH Metcalf, JS Demcheva, M Vournakis, J
Citation: Dj. Cole et al., A pilot study evaluating the efficacy of a fully acetylated poly-N-acetyl glucosamine membrane formulation as a topical hemostatic agent, SURGERY, 126(3), 1999, pp. 510-517
Risultati: 1-3 |